May & Baker, Nigeria Plc was based on September 4, 1944 as Nigeria’s first pharmaceutical firm. It has its origin in England, the United Kingdom the place in 1834, three chemists based Grimwade, May & Pickett, a agency for manufacturing chemical substances for pharmaceutical merchandise. In 1839 Grimwade, May & Pickett reworked into May & Baker United Kingdom Limited following some adjustments within the possession. May & Baker UK Limited reworked right into a mega European conglomerate by way of an online of mergers and acquisitions over years. Consequently the title of the corporate has modified at completely different occasions and at the moment, solely the Nigerian offshoot is thought by the unique title.
In Nigeria the corporate began as May & Baker (West Africa) Limited at 17A Tinubu Street, Lagos in 1944, a buying and selling outpost to serve the West Coast of Africa. The firm relocated to its current website at Ikeja, Lagos state in the course of the Nigerian civil warfare. In 1976, it constructed its manufacturing facility at Ikeja the place it started native manufacturing of prescribed drugs. That identical 12 months it modified from May & Baker (West Africa) Limited to May & Baker Nigeria Limited
In 1979, following the indigenisation decree which required that international pursuits in corporations working in Nigeria be of a minority nature, May & Baker, United Kingdom relinquished 60 per cent of its fairness holding in May & Baker Nigeria to Nigerians whereas retaining 40 per cent. The firm’s title was modified to Embechem Nigeria Limited however this was dropped later and the title reverted to May & Baker Nigeria Limited.
May & Baker Nigeria Limited grew to become a publicly quoted firm following its itemizing by introduction on the Nigerian Stock Exchange on November 10, 1994 and have become May & Baker Nigeria Plc.
For a few years expatriates despatched by the mother or father firm managed May & Baker Nigeria however in 1997, the primary indigenous Managing Director/Chief Executive Officer, Joseph Ikemefuna Odumodu, was appointed.
In 2002 the international companions determined to divest. However, represented by Aventis SA, France, they remained technical associates of May & Baker Nigeria Plc. Following the merger of Aventis and Sanofi, one other French agency to kind Sanofi Aventis in 2004, the technical relationship transferred between May & Baker Nigeria Plc and Sanofi-Aventis of France. But that relationship was renegotiated in 2005 to provide May & Baker Nigeria, the leeway to have its personal merchandise.
The firm thereby started an aggressive growth and diversification programme since 2005 which has culminated within the creation of latest companies and subsidiaries. In 2005, Biovaccines, a neighborhood vaccine manufacturing subsidiary was arrange in partnership with the Federal Government of Nigeria. In 2006, the corporate constructed a multi-billion naira meals processing manufacturing facility, constructed a neighborhood plant for the manufacturing of anti-retroviral medication in Nigeria whereas the development of a World Health Organization Standard Pharmaceutical manufacturing facility was constructed and commissioned on June 27, 2011Job Description
Reporting to the Head, Pharma Plant Operations, the incumbent might be anticipated to work inside and oversee the Quality Operation Team to realize high quality merchandise and guarantee compliance with laid down requirements.
The most well-liked candidate ought to possess a Degree in Pure Sciences, Membership of related skilled physique with 7 years related Pharmaceutical Manufacturing expertise.
Candidates should display a excessive degree of competence in Pharmaceutical high quality operations and possess robust individuals expertise.
Candidates should possess confirmed management expertise involving managing, creating and inspire groups to realize set goals.
He/ she have to be outcomes pushed, devoted to delivering sustainable top quality efficiency with wonderful data of Pharmaceutical cGMP and publicity to stringent worldwide Audits.
Attractive and negotiable